Skip to content

SCHEDULE 13D/AAccepted Aug 15, 4:54 PM ET

X4 Pharmaceuticals, Inc SCHEDULE 13D/A

Growth Equity Opportunities 18 VGE, LLC

Accepted (ET)

4:54 PM

Aug 15, 2025

Filed

Aug 15, 2025

Documents

3

Size

94.5 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.